NCT04123119View on ClinicalTrials.gov

Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2019

Conditions
Diarrhoeal Disease
Interventions
BIOLOGICAL

Rotavirus vaccine

An exploratory and observational cohort study following infants receiving two standard doses of live, attenuated, oral Rotarix™ administered at 6 \& 10 weeks.

Trial Locations (1)

10101

George Clinical Research Site, Lusaka

All Listed Sponsors
collaborator

Imperial College London

OTHER

collaborator

Christian Medical College, Vellore, India

OTHER

lead

Centre for Infectious Disease Research in Zambia

OTHER

NCT04123119 - Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model | Biotech Hunter | Biotech Hunter